Fady Hannah-shmouni MD, DABIM, FRCPC

Fady Hannah-Shmouni, MD ABIM FRCPC, is a physician-entrepreneur in endocrinology and genetics, assistant clinical professor of medicine at the University of British Columbia, and an investor and advisor for early-stage technology companies. His clinical and business interests are in precision medicine, endocrinology & metabolism, and investments/corporate development in disruptive technologies including blockchain, AI, and biotechnology.

Dr. Hannah-Shmouni is the Managing Partner and Co-Founder of FHS Capital and Tigris Digital, specializing in early-stage startup consultations and investments. He serves as a strategic advisor and consultant to several biotechnology and blockchain companies, focusing on strategic planning, operational skills, business support, and financing. He led several seed financing rounds, including; Ovenue Inc. (ovenue.com), a no-code AI and blockchain-enabled enterprise Platform-as-a-Service software company for real-world asset valuation, tokenization, and monetization; Flyby (flyby. global), a technology platform connecting last mile delivery with digital out of home advertising; and Fluus (fluus.com), the single gateway for web3 ramping needs to help onboard businesses and customers into the web3 economy.

Dr. Hannah-Shmouni completed clinical training in internal medicine at Yale School of Medicine; adult endocrinology, diabetes, and metabolism at the National Institutes of Health, America’s research hospital; and clinical biochemical genetics at the University of Toronto. He is board-certified in internal medicine and endocrinology by the American Board of Internal Medicine and Royal College of Physicians and Surgeons of Canada, and in clinical hypertension by the American Society of Hypertension. He is a staff physician at Vancouver General Hospital (UBC) and Trillium Health Partners (UofT), practicing endocrinology and internal medicine, and a fellow with the Royal College of Physicians and Surgeons of Canada. He was a physician-scientist in endocrinology and genetics at NIH (2015-2021), where he also served as Head of Graduate Medical Education and Associate Program Director of the endocrinology fellowship program at NICHD, NIH (2019-2021).